Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
<i>CHL1</i> hypermethylation as a potential biomarker of poor prognosis in breast cancer
Esperanza Martín‐Sánchez, Saioa Mendaza, Ane Ulazia-Garmendia, Iñaki Monreal‐Santesteban, Idoia Blanco‐Luquin, Alicia Córdoba, Francisco Vicente-García, Noemí Pérez‐Janices, David Escors, Diego Megı́as, Paula López-Serra, Manel Esteller, José Juan Illarramendi, David Guerrero‐Setas (2017). <i>CHL1</i> hypermethylation as a potential biomarker of poor prognosis in breast cancer. , 8(9), DOI: https://doi.org/10.18632/oncotarget.15004.
Article281 days ago<i>CHL1</i> hypermethylation as a potential biomarker of poor prognosis in breast cancer
Esperanza Martín‐Sánchez, Saioa Mendaza, Ane Ulazia-Garmendia, Iñaki Monreal‐Santesteban, Idoia Blanco‐Luquin, Alicia Córdoba, Francisco Vicente-García, Noemí Pérez‐Janices, David Escors, Diego Megı́as, Paula López-Serra, Manel Esteller, José Juan Illarramendi, David Guerrero‐Setas (2017). <i>CHL1</i> hypermethylation as a potential biomarker of poor prognosis in breast cancer. , 8(9), DOI: https://doi.org/10.18632/oncotarget.15004.
Article281 days ago<i>CHL1</i> hypermethylation as a potential biomarker of poor prognosis in breast cancer
Esperanza Martín‐Sánchez, Saioa Mendaza, Ane Ulazia-Garmendia, Iñaki Monreal‐Santesteban, Idoia Blanco‐Luquin, Alicia Córdoba, Francisco Vicente-García, Noemí Pérez‐Janices, David Escors, Diego Megı́as, Paula López-Serra, Manel Esteller, José Juan Illarramendi, David Guerrero‐Setas (2017). <i>CHL1</i> hypermethylation as a potential biomarker of poor prognosis in breast cancer. , 8(9), DOI: https://doi.org/10.18632/oncotarget.15004.
Article281 days agoEnhanced Risk Stratification of Smoldering Multiple Myeloma with Dynamic Biomarkers: A Multinational, Multicenter Study including 2,270 Participants (PANGEA 2.0)
Floris Chabrun, Daniel L. Schwartz, Susanna Gentile, K. Elias, Tulika Gupta, Jacqueline Perry, David M. Cordas dos Santos, Thomas Hielscher, Annika Werly, Silke Schmidt, Foteini Theodorakakou, Despina Fotiou, Christine‐Ivy Liacos, Nikolaos Kanellias, Noelia Collado Gisbert, Esperanza Martín‐Sánchez, Rosalinda Termini, Johannes M. Waldschmidt, Selina J Chavda, Louise Ainley, Matteo Da Vià, Claudio De Magistris, Loredana Pettine, Michael Timonian, Jean-Baptiste Alberge, Vidhi Patel, Patrick Costello, Christine M. Tobia, Sem H. Phan, Jennifer Lamb, Mauro Nicollas Oliveira Silvério, Maya Davis, Elizabeth O’Donnell, Catherine R. Marinac, Omar Nadeem, Niccolò Bolli, Kwee Yong, K. Martin Kortüm, Hermann Einsele, María‐Victoria Mateos, Shaji Kumar, Jesús F. San Miguel, Bruno Paiva, Efstathis Kastritis, Meletios A Dimopoulos, Marc S. Raab, Lorenzo Trippa, Irene M. Ghobrial (2025). Enhanced Risk Stratification of Smoldering Multiple Myeloma with Dynamic Biomarkers: A Multinational, Multicenter Study including 2,270 Participants (PANGEA 2.0). , DOI: https://doi.org/10.21203/rs.3.rs-6696313/v1.
Preprint14 days agoCharacterization of the plasma proteome of multiple myeloma and its precursor conditions and identification of a prognostic high-risk signature of progression
Elizabeth D. Lightbody, D.R. Mani, Hasmik Keshishian, Romanos Sklavenitis-Pistofidis, Ankit K. Dutta, Esperanza Martín‐Sánchez, Elise Rees, Christine‐Ivy Liacos, Nayda Bidikian, Habib El‐Khoury, Hadley Barr, Ting Wu, Junko Tsuji, Sarah Nersesian, Nang Kham Su, Cody J. Boehner, Michael P. Agius, Michelle P. Aranha, Sabrin Tahri, Laura Hevenor, Katherine Towle, Erica Horowitz, Jacqueline Perry, Maya Davis, Kelly A. Walsh, John E. Ready, Catherine R. Marinac, Kwee Yong, Gad Getz, Efstathios Kastritis, Meletios A Dimopoulos, Bruno Paiva, Namrata D. Udeshi, Michael A. Gillette, Steven A. Carr, Irene M. Ghobrial (2025). Characterization of the plasma proteome of multiple myeloma and its precursor conditions and identification of a prognostic high-risk signature of progression. , 146(Supplement 1), DOI: https://doi.org/10.1182/blood-2025-2168.
Article14 days ago